Evidence map›Paper›PMID 21170305›Full record

ArticlePLoS genetics2010

Investigation and functional characterization of rare genetic variants in the adipose triglyceride lipase in a large healthy working population.

Stefan Coassin, Martina Schweiger, Anita Kloss-Brandstätter, Claudia Lamina, Margot Haun, Gertraud Erhart, Bernhard Paulweber, Yusof Rahman, Simon Olpin, Heimo Wolinski and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Bayesian Genome-Wide Association Study of Feed Efficiency Traits in Pigs.Animals : an open access journal from MDPI · 2026
    Article
  3. Article
  4. Article
  5. A novel homozygous missense mutation inMolecular genetics and metabolism reports · 2023
    Article
  6. Article
  7. Review
  8. A novelGenes & diseases · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Of mice and men: The physiological role of adipose triglyceride lipase (ATGL).Biochimica et biophysica acta. Molecular and cell biology of lipids · 2019
    Review
  14. Review
  15. Article
  16. Metabolic lipid muscle disorders: biomarkers and treatment.Therapeutic advances in neurological disorders · 2019
    Review
  17. Article
  18. Lipid Myopathies.Journal of clinical medicine · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Stefan CoassinDivision of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria.
Martina Schweiger
Anita Kloss-Brandstätter
Claudia Lamina
Margot Haun
Gertraud Erhart
Bernhard Paulweber
Yusof Rahman
Simon Olpin
Heimo Wolinski
Irina Cornaciu
Rudolf Zechner
Robert Zimmermann
Florian Kronenberg
Innsbruck Medical University · ATUniversity of Graz · ATEvelina London Children's Healthcare · GBParacelsus Medical University · ATSheffield Children's Hospital · GB

Funding

Austrian Science Fund FWF F 3001Austrian Science Fund FWF F 3002Austrian Science Fund FWF Z 136
6 · The paper itself

Abstract

Recent studies demonstrated a strong influence of rare genetic variants on several lipid-related traits. However, their impact on free fatty acid (FFA) plasma concentrations, as well as the role of rare variants in a general population, has not yet been thoroughly addressed. The adipose triglyceride lipase (ATGL) is encoded by the PNPLA2 gene and catalyzes the rate-limiting step of lipolysis. It represents a prominent candidate gene affecting FFA concentrations. We therefore screened the full genomic region of ATGL for mutations in 1,473 randomly selected individuals from the SAPHIR (Salzburg Atherosclerosis Prevention program in subjects at High Individual Risk) Study using a combined Ecotilling and sequencing approach and functionally investigated all detected protein variants by in-vitro studies. We observed 55 novel mostly rare genetic variants in this general population sample. Biochemical evaluation of all non-synonymous variants demonstrated the presence of several mutated but mostly still functional ATGL alleles with largely varying residual lipolytic activity. About one-quarter (3 out of 13) of the investigated variants presented a marked decrease or total loss of catalytic function. Genetic association studies using both continuous and dichotomous approaches showed a shift towards lower plasma FFA concentrations for rare variant carriers and an accumulation of variants in the lower 10%-quantile of the FFA distribution. However, the generally rather small effects suggest either only a secondary role of rare ATGL variants on the FFA levels in the SAPHIR population or a recessive action of ATGL variants. In contrast to these rather small effects, we describe here also the first patient with "neutral lipid storage disease with myopathy" (NLSDM) with a point mutation in the catalytic dyad, but otherwise intact protein.

Indexed as

Genetic VariationAcyltransferasesAdultAgedAustriaFatty Acids, NonesterifiedFemaleHealth StatusHumansLipaseMaleMiddle AgedMutationPolymorphism, Single NucleotideProtein Structure, TertiaryWhite PeopleAcyltransferasesFatty Acids, NonesterifiedLipasePNPLA2 protein, human

Identifiers

PMID21170305
PMCPMC3000363
OpenAlexW1974852706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.